NVCT
Nuvectis PharmaยทNASDAQ
--
--(--)
--
--(--)
NVCT Profile
Nuvectis Pharma, Inc.
A biopharmaceutical company developing treatments for serious oncology-related diseases
1 Bridge Plaza, Suite 275, Fort Lee, NJ, 07024
--
Nuvectis Pharma, Inc., was incorporated under the laws of the State of Delaware on July 27, 2020. The Company is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious unmet medical oncology needs. The company's development strategy adopts a precision medicine-based approach to translate key scientific insights related to carcinogenic drivers, pathway addiction and their cancer-promoting factors into selective, potent and highly selective anticancer drugs. The company believes that these advances lay the foundation for the modern development of targeted therapies, which will enable the discovery and development of anti-cancer therapies based on tumor genetic characteristics rather than tumor histology.
